Figure 2.
Increased side effects with gabapentin/oxycodone versus gabapentin monotherapy in 338 patients with painful diabetic neuropathy (121). GI, gastrointestinal; CNS, central nervous system.
Increased side effects with gabapentin/oxycodone versus gabapentin monotherapy in 338 patients with painful diabetic neuropathy (121). GI, gastrointestinal; CNS, central nervous system.